On May 11, 2022, AbbVie Inc announced that at its annual general meeting of shareholders held on May 6, 2022, a shareholder proposal relating to adopt a policy to require an independent chair, was not approved.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
161.7 USD | -0.57% | -3.62% | +4.36% |
04-30 | Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent | MT |
04-29 | Health Care Up on Growth Optimism -- Health Care Roundup | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.36% | 286B | |
+33.25% | 699B | |
+28.59% | 571B | |
-3.55% | 364B | |
+18.16% | 326B | |
+14.81% | 236B | |
+4.93% | 198B | |
-9.78% | 194B | |
-3.69% | 149B | |
-5.59% | 154B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- Declaration of Voting Results by AbbVie Inc